ALL ALS Consortium Launches Website to Advance ALS Research The Access for All in ALS (ALL ALS) Consortium announced the launch of its official website,
Recent progress in therapeutics for amyotrophic lateral sclerosis (ALS) has spurred development and imbued the field of ALS with hope for more breakthroughs, yet substantial
The Access for All in ALS Consortium (ALL ALS) announced the successful enrollment of the first participant. Established in the autumn of 2023 with funding
ALS is a complex neurodegenerative disease, but the causes remain poorly understood and there are few effective therapies available. There is an urgent need for
The ALL ALS Consortium and all related studies are funded by the National Institutes of Health (NIH), Grant # 1OT2NS136938 and 1OT2NS136939.